Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical

Rhea-AI Summary

Inari Medical (NASDAQ: NARI) has filed a patent infringement lawsuit against Imperative Care and Truvic Medical. The lawsuit, lodged in the United States District Court for the Northern District of California, alleges that Truvic is infringing on eight Inari patents related to aspiration-based thrombectomy devices used for treating pulmonary emboli and deep vein thrombosis. Inari seeks injunctive relief and damages. CEO Drew Hykes emphasized the company's commitment to protecting its intellectual property rights, which are vital to its mission of improving patients' lives through innovative medical solutions.

Positive

• Inari Medical is actively protecting its intellectual property, which is important for its business.
• The company is seeking both injunctive relief and damages, which could result in financial compensation.
• Action emphasizes Inari's commitment to innovation and its mission to improve patient lives.

Negative

• Legal proceedings could be lengthy and costly, impacting Inari's finances.
• Litigation creates uncertainty, which could negatively affect investor sentiment and stock performance.
• Potential for counterclaims or legal defense costs from Imperative Care and Truvic Medical.

IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it had filed a patent infringement lawsuit against Imperative Care, Inc. and Truvic Medical, Inc. (collectively, “Truvic”). The suit was filed in the United States District Court for the Northern District of California. Inari is seeking injunctive relief and damages for infringement.

Inari believes Truvic is infringing eight of Inari Medical’s patents for the use of aspiration-based thrombectomy devices to treat pulmonary emboli and deep vein thrombosis. Truvic products named in the suit include the Symphony Thrombectomy System.

“Inari was founded to improve patients’ lives using purpose-built innovation. Our mission depends on these innovations, and we are deeply committed to protecting our intellectual property rights,” said Drew Hykes, CEO of Inari Medical.

About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous and other diseases. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn, X (Twitter), and Instagram.

Investor Contact:
John Hsu, CFA
VP, Investor Relations
949-658-3889
IR@inarimedical.com

FAQ

What is the recent lawsuit involving Inari Medical?

Inari Medical has filed a patent infringement lawsuit against Imperative Care and Truvic Medical.

Which companies are involved in the Inari Medical lawsuit?

The lawsuit is against Imperative Care and Truvic Medical.

What are the allegations in the lawsuit filed by Inari Medical?

Inari Medical alleges that Truvic Medical is infringing on eight of its patents involving thrombectomy devices.

When was the lawsuit filed by Inari Medical?

The lawsuit was filed on May 23, 2024.

What relief is Inari Medical seeking in the lawsuit?

Inari Medical is seeking injunctive relief and damages.

Where was Inari Medical's lawsuit filed?

The lawsuit was filed in the United States District Court for the Northern District of California.

Which Truvic Medical product is mentioned in Inari's lawsuit?

The Symphony Thrombectomy System is mentioned in the lawsuit.